From: Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa
 |  | KSHV Seropositivity | HIV Seropositivity | ||||
---|---|---|---|---|---|---|---|
 | Total (n) | Prevalence Total n(%) | Unadjusted OR# (95%CI) | Adjusted OR (95%CI) | Prevalence Total n(%) | Unadjusted OR (95%CI) | Adjusted OR# (95%CI) |
All Subjects | 1740 | 776(44.6%) | - | - | 402(23.1%) | - | - |
Age Group | Â | Â | Â | Â | Â | Â | Â |
   ≤ 20 | 362 | 154 (42.4) | 1 | 1 | 87(24.0%) | 1 | 1 |
   21 - 25 | 533 | 246 (46.2) | 1.2 (0.9 - 1.5) | 1.2 (0.9 - 1.7) | 136(25.5%) | 1.1 (0.8 - 1.5) | 1.1 (0.7 - 1.5) |
   26 - 30 | 438 | 192 (43.8) | 1.1 (0.8 - 1.4) | 1.1 (0.8 - 1.5) | 108(24.7%) | 1.0 (0.7 - 1.5) | 1.0 (0.7 - 1.5) |
   ≥ 31 | 407 | 184 (45.2) | 1.1 (0.8 - 1.5) | 1.2 (0.9 - 1.6) | 71(17.4%) | 0.7 (0.4 - 0.9)* | 0.7 (0.5 - 1.0)* |
P 3df | Â | Â | 0.6240 | 0.4830 | Â | 0.0286 | 0.0373 |
Municipality Region | Â | Â | Â | Â | Â | Â | Â |
   Soweto | 293 | 105(35.4) | 1 | 1 | 72(24.6%) | 1 | 1 |
   Ekurhuleni | 567 | 274 (48.3) | 1.6 (1.3 - 2.2)* | 1.8 (1.3 - 2.4) * | 147(25.9%) | 1.0 (0.7 - 1.5) | 1.1 (0.7 - 1.6) |
   Emfuleni | 330 | 152 (46.1) | 1.5 (1.1 - 2.1) * | 1.8 (1.1 - 2.6) * | 63(19.1%) | 0.8 (0.5 - 1.1) | 0.7 (0.5 - 1.1) |
   Tshwane | 207 | 77 (37.2) | 1.1 (0.7 - 1.5) | 1.3 (0.5 - 1.9) | 29(14.0%) | 0.5 (0.3 - 0.8)* | 0.5 (0.3 - 0.8)* |
   West Rand | 343 | 168 (49.0) | 1.7 (1.2 - 2.4) * | 1.7 (1.1 - 2.5) * | 91(22.6%) | 1.1 (0.8 - 1.6) | 1.1 (0.7 - 1.7) |
P 4df | Â | Â | 0.0015 | 0.0095 | Â | 0.0017 | 0.0013 |
Education Level | Â | Â | Â | Â | Â | Â | Â |
   < 2 years | 117 | 62 (53.0) | 1 | 1 | 17(14.5%) | 1 | 1 |
   2- 5 years | 513 | 253 (49.3) | 0.9 (0.6 - 1.3) | 0.7 (0.5 - 1.1) | 119(23.2%) | 1.3 (0.8 - 2.1) | 1.4 (0.8 - 2.6) |
   6 - 12 years | 119 | 51 (42.9) | 0.7 (0.4 - 1.1) | 0.5 (0.3 - 0.8)* | 31(26.0%) | 1.6 (0.8 - 3.1) | 1.4 (0.7 - 2.8) |
   Post Matric | 959 | 400 (41.7) | 0.6(0.4 - 0.9)* | 0.5 (0.4 - 0.8)* | 228(23.8%) | 1.4 (0.9 - 2.1) | 1.6 (0.9 - 2.8) |
P 3df | Â | Â | 0.0080 | 0.0034 | Â | 0.1645 | 0.3437 |
Gravidity Group | Â | Â | Â | Â | Â | Â | Â |
   1 | 631 | 269 (42.6) | 1 | - | 144(22.8%) | 1 | - |
   2 | 481 | 223 (46.4) | 1.2 (0.9 - 1.5) | - | 129(26.8%) | 1.2 (1.0 - 1.6)* | - |
   ≥2 | 532 | 246 (46.2) | 1.2 (0.9 - 1.5) | - | 106(28.0%) | 0.8 (0.6 - 1.1) | - |
P 2df | Â | Â | 0.2863 | Â | Â | 0.0284 | Â |
Parity group | Â | Â | Â | Â | Â | Â | Â |
   0 | 649 | 279 (43.0) | 1 | - | 149(23.0%) | 1 | - |
   1 | 487 | 223(45.8) | 1.1 (0.9 - 1.5) | - | 129(26.5%) | 1.2 (0.9 - 1.6) | - |
   > 2 | 506 | 235(46.4) | 1.2 (0.9 - 1.5) | - | 56(20.1%) | 0.9 (0.6 - 1.1) | - |
P 2df | Â | Â | 0.3594 | Â | Â | 0.0263 | Â |
River Catchment | Â | Â | Â | Â | Â | Â | Â |
   North | 279 | 109 (39.1) | 1 | - | 48(17.2%) | 1 | - |
   South | 1461 | 667 (45.6) | 0.8 (0.4 - 1.5) | - | 354(24.2%) | 0.6 (0.4 - 0.9)* | - |
P 1df | Â | Â | 0.4312 | Â | Â | 0.0075 | Â |
Syphilis | Â | Â | Â | Â | Â | Â | Â |
   Non-reactive | 1440 | 621 (43.1) | 1 | 1 | 303(21.0%) | 1 | 1 |
   Reactive | 298 | 154 (51.7) | 1.4 (1.1 - 1.8)* | 1.2 (0.9 - 1.6) | 97(32.5%) | 1.8 (1.4 - 2.4)* | 1.9 (1.4 - 2.5)* |
P 1df | Â | Â | 0.0028 | 0.1168 | Â | < 0.0001 | < 0.0001 |
HIV infection | Â | Â | Â | Â | Â | Â | Â |
   Negative | 1338 | 496 (37.1) | 1 | 1 |  | - | - |
   Positive | 402 | 280 (69.7) | 3.9 (3.1 - 5.0)* | 4.1 (3.1 - 5.2)* |  | - | - |
   P 1df |  |  | < 0.0001 | < 0.0001 |  |  |  |